MECP2 and pulmonary fibrosis: To further evaluate the therapeutic effects of Mecp2 siRNA‐loaded liposomes on pulmonary fibrosis, we measured the expression of fibrotic markers (fibronectin, collagen 1, and α‐SMA) in the lung.